Campos Carrascosa, L., van Beek, A. A., de Ruiter, V., Doukas, M., Wei, J., Fisher, T. S., Ching, K., Yang, W., van Loon, K., Boor, P. P. C., Rakké, Y. S., Noordam, L., Doornebosch, P., Grünhagen, D., Verhoef, K., Polak, W. G., IJzermans, J. N. M., Ni, I., Yeung, Y. A., Salek-Ardakani, S., Sprengers, D., & Kwekkeboom, J. (2020). fcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells. Journal for immunotherapy of cancer, 8(2), . http://access.bl.uk/ark:/81055/vdc_100127559568.0x000034